SCHEMBL14972769

SCHEMBL14972769

COC(=O)ON1CCN(c2ccc3ncc(Cc4c(F)cc5ncccc5c4F)n3n2)CC1

nearest known ligand 0.58

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MET P08581 20/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1161766 0.90 MET (0.60) MET
SCHEMBL1190930 0.87 MET (0.61) MET
SCHEMBL1161358 0.85 MET (0.59) MET
SCHEMBL14972797 0.83 MET (0.54) MET
SCHEMBL1161726 0.83 MET (0.55) MET
SCHEMBL1161398 0.82 MET (0.57) MET
SCHEMBL1161263 0.81 MET (0.55) MET
SCHEMBL14972737 0.78 MET (0.51) MET
SCHEMBL1160980 0.78 MET (0.53) MET
SCHEMBL1161552 0.74 MET (0.46) MET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2462143-B1 3-HETEROARYLMETHYL-IMIDAZO[1,2-B]PYRIDAZIN-6-YL DERIVATIVES AS C-MET TYROSINE KINASE MODULATORS NOVARTIS AG (CH) 2013-05-29 EP claimed